评估抑郁症咨询对比认知行为疗法治疗基层医疗中符合中度或重度抑郁症诊断患者的非劣效性实用随机对照试验(PRaCTICED):随机对照试验研究方案
PRaCTICED为双臂平行组非劣效性随机对照试验,在IAPT阶梯式照护服务中比较抑郁症咨询(CfD)与认知行为疗法(CBT)。纳入18岁及以上、需第3步干预且符合ICD-10中度或重度抑郁症诊断的患者,随机接受最多20次治疗,主要结局为基线、6个月和12个月的PHQ-9。需500例(每组250例)检验CfD相对CBT在PHQ-9上-2分非劣效假设。
要点
- PRaCTICED在IAPT服务中比较CfD与CBT,采用非劣效性设计,主要结局为PHQ-9。
- 样本量500例(每组250例),非劣效界值-2分PHQ-9,单侧2.5%显著性水平,把握度90%。
- 主要分析基于意向性治疗人群,并辅以符合方案集和依从者平均因果效应分析。
核心结论
- 该试验旨在提供CfD对比CBT在常规IAPT服务中疗效和成本效果的证据,目前为研究方案,尚未报告结局结果。
研究设计与样本
- PRaCTICED为双臂平行组非劣效性随机对照试验,比较CfD与CBT,嵌入当地IAPT服务第3步常规照护。
- 纳入标准为18岁及以上、希望处理抑郁问题、被判定需要第3步干预且符合ICD-10中度或重度抑郁症诊断的患者。
- 通过集中式网络系统随机分配至CfD或CBT,每种治疗最多20次。
- 两种干预均手册化,治疗保真度通过督导和随机抽取会谈使用依从性/能力量表评估。
- 试验需500例患者(每组250例),以单侧2.5%显著性水平和90%把握度检验-2分PHQ-9的非劣效假设,假设无组间差异且标准差为6.9。
主要发现
- 主要结局为基线、6个月和12个月采集的PHQ-9。
- 次要结局涵盖抑郁、一般心理困扰、焦虑、功能和生活质量。
- 成本效果通过患者服务使用问卷确定。
- 由对治疗分配设盲的研究评估员对患者进行退出访谈。
关键数值与推荐
- 非劣效性假设为PHQ-9差值-2分,单侧2.5%显著性水平,90%把握度,假设无 underlying 差异且标准差为6.9。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: NICE guidelines state cognitive behavioural therapy (CBT) is a front-line psychological treatment for people presenting with depression in primary care. Counselling for Depression (CfD), a form of Person-Centred Experiential therapy, is also offered within Improving Access to Psychological Therapies (IAPT) services for moderate depression but its effectiveness for severe depression has not been investigated. A full-scale randomised controlled trial to determine the efficacy and cost-effectiveness of CfD is required. METHODS: PRaCTICED is a two-arm, parallel group, non-inferiority randomised controlled trial comparing CfD against CBT. It is embedded within the local IAPT service using a stepped care service delivery model where CBT and CfD are routinely offered at step 3. Trial inclusion criteria comprise patients aged 18 years or over, wishing to work on their depression, judged to require a step 3 intervention, and meeting an ICD-10 diagnosis of moderate or severe depression. Patients are randomised using a centralised, web-based system to CfD or CBT with each treatment being delivered up to a maximum 20 sessions. Both interventions are manualised with treatment fidelity tested via supervision and random sampling of sessions using adherence/competency scales. The primary outcome measure is the Patient Health Questionnaire-9 collected at baseline, 6 and 12 months. Secondary outcome measures tap depression, generic psychological distress, anxiety, functioning and quality of life. Cost-effectiveness is determined by a patient service receipt questionnaire. Exit interviews are conducted with patients by research assessors blind to treatment allocation. The trial requires 500 patients (250 per arm) to test the non-inferiority hypothesis of -2 PHQ-9 points at the one-sided, 2.5% significance level with 90% power, assuming no underlying difference and a standard deviation of 6.9. The primary analysis will be undertaken on all patients randomised (intent to treat) alongside per-protocol and complier-average causal effect analyses as recommended by the extension to the CONSORT statement for non-inferiority trials. DISCUSSION: This large-scale trial utilises routinely collected outcome data as well as specific trial data to provide evidence of the comparative efficacy and cost-effectiveness of Counselling for Depression compared with Cognitive Behaviour Therapy as delivered within the UK government's Improving Access to Psychological Therapies initiative. TRIAL REGISTRATION: Controlled Trials ISRCTN Registry, ISRCTN06461651 . Registered on 14 September 2014.
引用
- Saxon D, Ashley K, Bishop-Edwards L, et al. A pragmatic randomised controlled trial assessing the non-inferiority of counselling for depression versus cognitive-behaviour therapy for patients in primary care meeting a diagnosis of moderate or severe depression (PRaCTICED): Study protocol for a randomised controlled trial. Trials. 2017. PMID: 28249592. doi:10.1186/s13063-017-1834-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。